Live Quote · NASDAQCYCCHealthcare· Biotechnology

Cyclacel Pharmaceuticals, Inc.

$6.37▼ 5.98%($-0.41)
MKT CAP $10.61MLAST EARNINGS Aug 12, 2025
50%
Bullish
TickerSpark Score
55/100
▌ Mixed
90
Valuation
30
Profitability
55
Growth
68
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CYCC research report →

Analyst Price Target
$1.00-84.3% vs. today

Range $1 – $1

Analyst RatingBuy
5 Buy2 Hold0 Sell

Price Chart

-90.67% · this period
$1047.08$564.82$82.56Dec 06Jun 07Dec 05
52-Week Range1% of range
Low
$3.08
Current
$6.37
High
$597.60